PeQuiM-Laboratory of Research in Medicinal Chemistry, Federal University of Alfenas, Jovino Fernandes Sales Avenue 2600, Alfenas, MG, 37130-840, Brazil.
Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto 237, 47921, Rimini, Italy.
Neurochem Res. 2020 Dec;45(12):3003-3020. doi: 10.1007/s11064-020-03148-2. Epub 2020 Oct 20.
A new series of ten multifunctional Cinnamoyl-N-acylhydrazone-donepezil hybrids was synthesized and evaluated as multifunctional ligands against neurodegenerative diseases. The molecular hybridization approach was based on the combination of 1-benzyl-4-piperidine fragment from the anti-Alzheimer AChE inhibitor donepezil (1) and the cinnamoyl subunit from curcumin (2), a natural product with remarkable antioxidant, neuroprotective and anti-inflammatory properties, using a N-acylhydrazone fragment as a spacer subunit. Compounds 4a and 4d showed moderate inhibitory activity towards AChE with IC values of 13.04 and 9.1 µM, respectively. In addition, compound 4a and 4d showed a similar predicted binding mode to that observed for donepezil in the molecular docking studies. On the other hand, compounds 4a and 4c exhibited significant radical scavenging activity, showing the best effects on the DPPH test and also exhibited a significant protective neuronal cell viability exposed to t-BuOOH and against 6-OHDA insult to prevent the oxidative stress in Parkinson's disease. Similarly, compound 4c was capable to prevent the ROS formation, with indirect antioxidant activity increasing intracellular GSH levels and the ability to counteract the neurotoxicity induced by both OAβ1-42 and 3-NP. In addition, ADMET in silico prediction indicated that both compounds 4a and 4c did not show relevant toxic effects. Due to their above-mentioned biological properties, compounds 4a and 4c could be explored as lead compounds in search of more effective and low toxic small molecules with multiple neuroprotective effects for neurodegenerative diseases.
合成了一系列十种新型多功能肉桂酰-N-酰腙-多奈哌齐杂合化合物,并将其作为针对神经退行性疾病的多功能配体进行了评估。该分子杂化方法基于将来自阿尔茨海默病 AChE 抑制剂多奈哌齐(1)的 1-苄基-4-哌啶片段与姜黄素(2)的肉桂酰亚基结合,使用 N-酰腙片段作为间隔子亚基,姜黄素是一种具有显著抗氧化、神经保护和抗炎特性的天然产物。化合物 4a 和 4d 对 AChE 表现出适度的抑制活性,IC 值分别为 13.04 和 9.1µM。此外,在分子对接研究中,化合物 4a 和 4d 表现出与多奈哌齐相似的预测结合模式。另一方面,化合物 4a 和 4c 表现出显著的自由基清除活性,在 DPPH 试验中表现出最佳效果,并且对 t-BuOOH 暴露的神经元细胞活力具有显著的保护作用,并能防止帕金森病中的氧化应激。同样,化合物 4c 能够防止 ROS 形成,具有间接抗氧化活性,增加细胞内 GSH 水平,并能够抵抗 OAβ1-42 和 3-NP 诱导的神经毒性。此外,ADMET 计算预测表明,化合物 4a 和 4c 均不会显示出相关的毒性作用。由于它们具有上述生物学特性,化合物 4a 和 4c 可以作为先导化合物进行探索,以寻找更有效、低毒的具有多种神经保护作用的小分子,用于治疗神经退行性疾病。